tiprankstipranks
Trending News
More News >
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market
Advertisement

Qyuns Therapeutics Co., Ltd. Class H (2509) Revenue

Compare
0 Followers

Qyuns Therapeutics Co., Ltd. Class H Revenue

Qyuns Therapeutics Co., Ltd. Class H had a revenue of 56.94M in the quarter ending Dec 31, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 158.79M, Decreased 42.32%. In the fiscal year ending Dec 31, 2024, Qyuns Therapeutics Co., Ltd. Class H had annual revenue of 158.79M with 976.49% growth.
Revenue (ttm)
158.79M
Revenue Growth
P/S Ratio
Revenue/Employee
HK$468,416
Employees
339
Market Cap

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
158.79M144.04M+976.49%
Dec 31, 2023
14.75M5.09M+52.67%
Dec 31, 2022
9.66M-11.69M-54.74%
Dec 31, 2021
21.35M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis